-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q2 2024.
- SAB Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 9.26M shares, a 83.6% increase year-over-year.
- SAB Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 5.52M shares, a 26.9% increase from 2022.
- SAB Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4.35M shares, a 84.1% decline from 2021.
- SAB Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 27.3M shares, a 1.21% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)